Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.47 |
| ▸ | ACE | P12821 | 5/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 5/20 | 0.46 |
| ▸ | CPA1 | P15085 | 4/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3870647 | 1.00 | MME (0.47) | MMEACEACE2CPA1FOLH1 | |
| SCHEMBL12864805 | 0.87 | MME (0.50) | MMEACEACE2CPA1FOLH1 | |
| SCHEMBL13957703 | 0.87 | MME (0.50) | MMEACEACE2CPA1FOLH1 | |
| SCHEMBL5738141 | 0.85 | FOLH1 (0.61) | MMEACEACE2CPA1FOLH1 | |
| SCHEMBL30063730 | 0.85 | TDP1 (0.52) | MMEACEACE2CPA1FOLH1 | |
| SCHEMBL12869808 | 0.85 | FOLH1 (0.61) | MMEACEACE2CPA1FOLH1 | |
| SCHEMBL2781126 | 0.84 | MME (0.58) | MMEACEACE2CPA1L3MBTL1 | |
| SCHEMBL15592756 | 0.84 | MME (0.58) | MMEACEACE2CPA1L3MBTL1 | |
| SCHEMBL123574 | 0.84 | MME (0.58) | MMEACEACE2CPA1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL6774734 | 0.83 | MME (0.47) | MMEACEACE2CPA1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313835-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2025-10-09 | — | — | US | disclosed |
| EP-4603589-A2 | MICELLAR NANOPARTICLES AND USES THEREOF | Biorchestra Co., Ltd. (KR) | 2025-08-20 | — | — | EP | disclosed |
| WO-2025149946-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2025-07-17 | — | — | WO | disclosed |
| EP-3990028-B1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO LTD (KR) | 2025-06-04 | — | — | EP | disclosed |
| EP-4551193-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | Biorchestra Co., Ltd. (KR) | 2025-05-14 | — | — | EP | disclosed |
| CN-114514038-B | Micelle nanoparticle and use thereof | 生物欧赛加有限责任公司 | 2024-08-06 | — | — | CN | disclosed |
| US-20240209035-A1 | POLYNUCLEOTIDES CAPABLE OF ENHANCED PROTEIN EXPRESSION AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| WO-2024127317-A1 | TREATING MITOCHONDRIAL DYSFUNCTION WITH MIRNA-485 INHIBITOR | BIORCHESTRA CO., LTD. (KR) | 2024-06-20 | — | — | WO | disclosed |
| US-20240173348-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2024-05-30 | — | — | US | disclosed |
| US-20240131048-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO., LTD. (KR) | 2024-04-25 | — | — | US | disclosed |
| US-20090076076-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | BAYLOR UNIVERSITY (US) | 2009-03-19 | — | — | US | disclosed |
| US-7495023-B2 | Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-02-24 | — | — | US | disclosed |
| US-20070197495-A1 | ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-08-23 | — | — | US | disclosed |
| EP-1734939-A1 | ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE | The Regents of The University of California (US) | 2006-12-27 | — | — | EP | disclosed |
| US-20060128690-A1 | Amine derivative | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-06-15 | — | — | US | disclosed |
| EP-1593667-A1 | AMINE DERIVATIVE | Takeda Pharmaceutical Company Limited (JP) | 2005-11-09 | — | — | EP | disclosed |
| WO-2005087211-A1 | ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-09-22 | — | — | WO | disclosed |
| US-20050182121-A1 | Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-08-18 | — | — | US | disclosed |
| US-6897240-B2 | Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-05-24 | — | — | US | disclosed |
| US-20040014801-A1 | Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014801-A1 | Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use | CTSB, CTSS, CTSL | MME 253/4885ACE 270/4885ACE2 546/4885 |
| US-20050182121-A1 | Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use | CTSB, CTSS, CSTB | MME 346/4885ACE 352/4885ACE2 609/4885 |
| US-20240131048-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | HNRNPLL, UACA, POLRMT | MME 2393/4885ACE 4723/4885ACE2 4637/4885 |
| US-20240209035-A1 | POLYNUCLEOTIDES CAPABLE OF ENHANCED PROTEIN EXPRESSION AND USES THEREOF | UPF1, PABPC4, NSUN3 | MME 2493/4885ACE 4175/4885ACE2 2967/4885 |
| US-20060128690-A1 | Amine derivative | MC1R, MC2R, MC4R | MME 2936/4885ACE 3962/4885ACE2 2622/4885 |
| US-20090076076-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | CTSB, CTSS, CTSZ | MME 139/4885ACE 261/4885ACE2 468/4885 |
| US-20250313835-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | HNRNPLL, UACA, POLRMT | MME 2393/4885ACE 4723/4885ACE2 4637/4885 |
| US-20240173348-A1 | MICELLAR NANOPARTICLES AND USES THEREOF | TLR9, HNRNPLL, POLRMT | MME 1940/4885ACE 4605/4885ACE2 4532/4885 |
| US-20070197495-A1 | ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE | CYP51A1, TUBA3C, PIGO | MME 1087/4885ACE 1051/4885ACE2 1586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.